Watch ecancer's expert panel debate the new agents in multiple myeloma with a focus on monoclonal antibodies

Live on the 14th of April at 17:00-18:00 CEST.

Michel Delforge (Belgium), Hermann Einsele (Germany), Philippe Moreau (France) and Niels van de Donk (Netherlands) review updates on new agents in multiple myeloma – focusing on monoclonal antibodies.

After viewing this broadcast you should be able to summarise key clinical data and practical management approaches with monoclonal antibodies in multiple myeloma and discuss the rationale for their use in multiple myeloma therapy.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).